Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Comments
Loading...
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF
THNRARCA
Sector
Unknown
Region
US
AUM
3.76M
Fund Score
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) Quotes, Forecast and News Summary
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) stock price, news, charts, stock research, profile.
| Open | - |
| High | - |
| 52 Wk High | $28.19 |
| AUM | 3.76M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 193 |
| Market Cap | - |
| Mgmt Fee | 0.59% |
| P/E Ratio | - |
| Prev. Close | $23.36 |
| Low | - |
| 52 Wk Low | $22.57 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 3.71K |
| Beta | 0.80 |
| Avg. Expense Ratio | 0.59% |
| P/B Ratio | - |
Recent News
FAQ
Q
How do I buy Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
You can purchase shares of Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) through any online brokerage.
Q
Who are Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) competitors?
A
There are no as such competitors for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
Q
What is the forecast, or price target, for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) stock?
A
There is no analysis for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF to provide a consensus price target.
Q
What is the current price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR)?
A
The stock price for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA: THNR) is $23.44 last updated November 25, 2024 at 9:30 AM EST.
Q
Does Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) pay a dividend?
A
There are no upcoming dividends for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
Q
When is Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (ARCA:THNR) reporting earnings?
A
Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF does not have any upcoming earnings scheduled.
Q
Is Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF (THNR) going to split?
A
There is no upcoming split for Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF.
| Open | - |
| High | - |
| 52 Wk High | $28.19 |
| AUM | 3.76M |
| Dividend | - |
| Ex-Div Date | - |
| Volume | 193 |
| Market Cap | - |
| Mgmt Fee | 0.59% |
| P/E Ratio | - |
| Prev. Close | $23.36 |
| Low | - |
| 52 Wk Low | $22.57 |
| Shares Out | - |
| Yield | - |
| Div. Freq | - |
| Avg. Volume Daily | 3.71K |
| Beta | 0.80 |
| Avg. Expense Ratio | 0.59% |
| P/B Ratio | - |
ETF Details
| Sector | Unknown |
| Category | - |
| Investment Style | Large Cap Blend |
| Fund Inception | May 21, 2024 |
| Managers | Christine Johanson Dustin Lewellyn Ernesto Tong |
| Definition | - |
Investment Policy
The Fund invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the Index. VettaFi LLC, a wholly-owned subsidiary of TMX Group Limited developed and maintains the Index (the Index Provider).
Popular Channels
Tools & Features
Partners & Contributors
About Benzinga
© 2024 Benzinga | All Rights Reserved